Mendelian Susceptibility to Mycobacterial Disease

Cardiovascular

Prevalence

0.1 / 100K

0 drugs in development·0 companies·1 clinical trial

Frequently asked questions

How many clinical trials target Mendelian Susceptibility to Mycobacterial Disease?

There are 1 clinical trial targeting Mendelian Susceptibility to Mycobacterial Disease tracked by BioSniper.

What is the prevalence of Mendelian Susceptibility to Mycobacterial Disease?

The estimated prevalence of Mendelian Susceptibility to Mycobacterial Disease is approximately 0.1 per 100,000 population.

Deep-dive into Mendelian Susceptibility to Mycobacterial Disease

Full trial data, competitive analysis, and AI-powered pipeline tracking.

Start Free Analysis
    Mendelian Susceptibility to Mycobacterial Disease — Drugs in Development & Clinical Trials | BioSniper